A review of the literature was undertaken in order to ascertain the epidemiology of DIP in older adults (aged 65 or older) caused by APs (antipsychotic-induced parkinsonism—AIP) as well as D2R antagonists; and establish its clinical characteristics, differential diagnosis, management, and prognosis. The gene discussed is DRD2; the disease is autoimmune pancreatitis.